The DOI matches its Crossref record; 57 of the 71 references it cites were found in a registry or an index.
DNA damage induces phosphorylation of the amino terminus of p53
Open accessAbstract
Data are presented demonstrating that DNA damage leads to specific post-translational modifications of p53 protein. Using two-dimensional peptide mapping of in vivo radiolabeled p53 tryptic phosphopeptides, recombinant truncated p53 protein, and synthetic p53 tryptic peptides, a unique p53 phosphopeptide was identified after exposure of ML-1 cells to ionizing irradiation. This peptide represents the first 24 amino acids of p53 and contains three phosphorylated serine residues. A specific p53 phosphopeptide antibody identified serine-15 as one of the two serines in p53 that becomes phosphorylated following DNA damage induced by either ionizing irradiation (IR) or ultraviolet (UV) irradiation in multiple cell types. IR-induced phosphorylation of p53 does not affect the kinetics of p53 binding to or dissociating from DNA as assessed by electrophoretic mobility-shift assays. However, p53 phosphorylation induced by DNA damage correlates with enhanced transcription of downstream p53 target genes. Low levels of phosphoserine-15 p53 are detectable within 6 hr after IR in AT cells, whereas lymphoblasts from normal individuals exhibit this modification within 1 hr. In contrast, phosphorylation of p53 on serine-15 is similar in normal and AT cells after UV irradiation. Our results indicate that p53 is phosphorylated in response to DNA damage, that this de novo phosphorylation may be involved in the subsequent induction and activation of p53, and that although ATM affects the kinetics of p53 phosphorylation after IR, it is not absolutely required for phosphorylation of p53 on serine-15.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Doxorubicin treatment of early passage tumor cell lines revealed that five of five early generation mTerc Ink4a / Arf -/ -tumors maintained intact p53 response evidenced by p53 Ser-18 phosphorylation (37, 38) and associated induction of p21 CIP1 .”
From Ink4a / Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse (2007) · cites this paper as [38]
Experimental — accuracy not yet measuredIn the citing paper
“Induction of double strand breaks in DNA by ionizing radiation or genotoxic chemotherapy leads to the rapid stabilization of p53 through phosphorylation of its N terminus (Shieh et al. 1997; Siliciano et al. 1997”
From p53 Deficiency Rescues the Adverse Effects of Telomere Loss and Cooperates with Telomere Dysfunction to Accelerate Carcinogenesis (1999) · cites this paper as Siliciano et al. 1997
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Participation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 3,761
Self-citationRegulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · cited 1×
“It has been demonstrated recently that the mechanism for this inhibition involves binding Mdm2 to p53 and targeting p53 for rapid degradation (Haupt et al. 1997; Kubbutat et al. 1997).”
BackgroundDérijard, B., Hibi, M., Wu, I.-H., Barrett, T., Su, B., Deng, T., Karin, M., & Davis, R. J. (1994) · Cell · doi:10.1016/0092-8674(94)90380-8 · Cited by 3,188
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
Self-citationA Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase
Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., et al. (1995) · Science · doi:10.1126/science.7792600 · Cited by 2,785
Hartwell, L. H., & Kastan, M. B. (1994) · Science · doi:10.1126/science.7997877 · Cited by 2,539
Self-citationp53: puzzle and paradigm.Preprint
Ko, L. J., & Prives, C. L. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,346
Cited by
Sorted by citations
Items 601–700 of 815
Khanal, P., Lee, K.-Y., Kang, K.-W., Kang, B. S., & Choi, H. S. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp040 · Cited by 15
The TP53 signaling network in mammals and worms
Jolliffe, A. K., & Derry, W. B. (2012) · Briefings in Functional Genomics · doi:10.1093/bfgp/els047 · Cited by 14
Quinoline-based compounds can inhibit diverse enzymes that act on DNA
Zhou, J., Chen, Q., Ren, R., Yang, J., Liu, B., Horton, J. R., Chang, C., Li, C., Maksoud, L., Yang, Y., et al. (2024) · Cell chemical biology · doi:10.1016/j.chembiol.2024.09.007 · Cited by 13
p53 Activation by Cr(VI): A Transcriptionally Limited Response Induced by ATR Kinase in S-Phase
Łuczak, M. W., Krawic, C., & Zhitkovich, A. (2019) · Toxicological Sciences · doi:10.1093/toxsci/kfz178 · Cited by 13
Repression of Irs2 by let‐7 miRNAs is essential for homeostasis of the telencephalic neuroepithelium
Fernández, V., Martínez‐Martínez, M. Á., Prieto‐Colomina, A., Cárdenas, A., Soler, R., Dori, M., Tomasello, U., Nomura, Y., López‐Atalaya, J. P., Calegari, F., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2020105479 · Cited by 15
Chakrabarti, A., Gupta, K., Sharma, J. P., Yang, J., Agarwal, A., Glick, A., Zhang, Y., Agarwal, M. L., Agarwal, M. K., & Wald, D. N. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.312801 · Cited by 12
Thayyullathil, F., Chathoth, S., Kizhakkayil, J., Galadari, A., Hago, A., Patel, M. C., & Galadari, S. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.05.156 · Cited by 12
Verduzco, D., Dovey, J. S., Shukla, A. A., Kodym, E., Skaug, B. A., & Amatruda, J. F. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0072 · Cited by 12
Validation of a genotoxicity test based on p53R2 gene expression in human lymphoblastoid cells
Mizota, T., Ohno, K., & Yamada, T. (2011) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2011.06.003 · Cited by 12
The p53 Tumour Suppressor Protein
Hickman, E. S., & Helin, K. (2000) · Biotechnology and Genetic Engineering Reviews · doi:10.1080/02648725.2000.10647992 · Cited by 12
Therapeutic strategies for head and neck cancer based on p53 status
Ota, I., Okamoto, N., Yane, K., Takahashi, A., Masui, T., Hosoi, H., & Ohnishi, T. (2012) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2012.474 · Cited by 11
Sokolov, M. V., Neumann, R. D., & Panyutin, I. G. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-192 · Cited by 11
Analysis of DNA-damage response to ionizing radiation in serum-shock synchronized human fibroblasts
Corrà, S., Salvadori, R., Bee, L., Barbieri, V., & Mognato, M. (2017) · Cell Biology and Toxicology · doi:10.1007/s10565-017-9394-9 · Cited by 13
El‐Hafeez, A. A. A., Fujimura, T., Kamei, R., Hirakawa, N., Baba, K., Ono, K., & Kawamoto, S. (2017) · Cytotechnology · doi:10.1007/s10616-017-0116-1 · Cited by 12
Molecular Mechanisms of Pre-T Cell Receptor-induced Survival
Murga, C., & Barber, D. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203553200 · Cited by 11
Chromosomal DNA and p53 Stability, Ubiquitin System and Apoptosis in B-CLL Lymphocytes
Blaise, R., Masdehors, P., Laugé, A., Stoppa‐Lyonnet, D., Alapetite, C., Merle‐Béral, H., Binet, J., Ōmura, S., Magdelénat, H., Sabatier, L., et al. (2001) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190109097742 · Cited by 11
p53 Phosphorylation in Mouse Skin and In vitro Human Skin Model by High-dose-radiation Exposure
Koike, M., Sugasawa, J., Koike, A., & Kohno, Y. (2005) · Journal of Radiation Research · doi:10.1269/jrr.46.461 · Cited by 11
Uchihara, Y., Tago, K., Tamura, H., & Funakoshi‐Tago, M. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12822 · Cited by 10
DYRK2 maintains genome stability via neddylation of cullins in response to DNA damage
Kawamura, A., Yoshida, S., Aoki, K., Shimoyama, Y., Yamada, K., & Yoshida, K. (2022) · Journal of Cell Science · doi:10.1242/jcs.259514 · Cited by 10
ATM and ATR checkpoint kinase pathways: A concise review
Chauhan, N., Wagh, V., Joshi, P., & Jariyal, H. (2020) · Advances in Human Biology · doi:10.4103/aihb.aihb_78_19 · Cited by 9
Hainaut, P. L., Wiman, K. G., & Olivier, M. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3676-8 · Cited by 10
Ozen, M., Lipniacki, T., Levchenko, A., Emamian, E. S., & Abdi, A. (2020) · Integrative Biology · doi:10.1093/intbio/zyaa009 · Cited by 10
Thelestam, M., & Frisan, T. (2006) · Elsevier eBooks · doi:10.1016/b978-012088445-2/50028-7 · Cited by 10
Dose-dependent mutual regulation between Wip1 and p53 following UVC irradiation
Xia, Y. F., Yang, Q., Gong, X., Ye, F., & Liou, Y. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.12.009 · Cited by 9
Jardı́, M., Saito, S., Appella, E., Vidal, B., Parra, M., & Muñoz‐Cánoves, P. (2005) · Thrombosis and Haemostasis · doi:10.1160/th04-10-0644 · Cited by 10
Self-citationZhang, J., Ma, Z., Wang, J., Li, S., Zhang, Y., Wang, Y., Wang, M., Feng, X., Liu, X., Liu, G., et al. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.12.008 · Cited by 10
Effects of Hylomecon vernalis ethanol extracts on cell cycle and apoptosis of colon cancer cells
Sun, J., Zhang, X., Sun, Y., Tang, Z., & Guo, D.-Y. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6426 · Cited by 10
Takabatake, K., Konishi, H., Arita, T., Kataoka, S., Shibamoto, J., Furuke, H., Takaki, W., Shoda, K., Shimizu, H., Yamamoto, Y., et al. (2021) · Oncology Reports · doi:10.3892/or.2021.8211 · Cited by 9
Antunović, M., Matić, I., Nagy, B., Mihalić, K. C., Skelin, J., Štambuk, J., Josipović, P., Bender, T., Paradžik, M., & Marijanović, I. (2019) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2019.03.007 · Cited by 9
Voss, L., Guttek, K., Reddig, A., Reinhold, A., Voß, M., Schraven, B. L., & Reinhold, D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.616570 · Cited by 9
Characterization of Ninjurin and TSC22 induction after X‐irradiation of normal human skin cells
Koike, M., Ninomiya, Y., & Koike, A. (2007) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2007.00404.x-i1 · Cited by 9
Targeting the Cell Cycle to Kill Cancer Cells
Taylor, W. R., & Grabovich, A. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-369521-5.00017-8 · Cited by 9
Reynolds, R. P., Witherspoon, S. M., & Fox, T. R. (2004) · Molecular Carcinogenesis · doi:10.1002/mc.20017 · Cited by 9
Inoue, Y., Yamashita, N., Kitao, H., Tanaka, K., Saeki, H., Oki, E., Oda, Y., Tokunaga, E., & Maehara, Y. (2017) · Clinical Breast Cancer · doi:10.1016/j.clbc.2017.11.008 · Cited by 10
Bromamine T (BAT) Exerts Stronger Anti-Cancer Properties than Taurine (Tau)
Baliou, S., Goulielmaki, M., Ιωάννου, Π., Cheimonidi, C., Trougakos, I. P., Nagl, M., Kyriakopoulos, A. M., & Zoumpourlis, V. C. (2021) · Cancers · doi:10.3390/cancers13020182 · Cited by 8
Low-dose Radiation Effects and Intracellular Signaling Pathways
Suzuki, K., Kodama, S., & Watanabe, M. (2006) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.126.859 · Cited by 8
Choi, S., Koh, D., Cho, S.-Y., Kim, M.-K., Kim, K., & Hur, M. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.008100 · Cited by 7
Gatekeepers of the Guardian: p53 Regulation by Post-Translational Modification, MDM2 and MDMX
Wahl, G. M., Stommel, J. M., Krummel, K. A., & Wade, M. R. (2005) · Springer eBooks · doi:10.1007/978-1-4020-2922-6_4 · Cited by 9
Vikhanskaya, F., & Broggini, M. (2002) · International review of cytology · doi:10.1016/s0074-7696(02)19013-9 · Cited by 8
White, J. S., Yue, N. J., Hu, J., & Bakkenist, C. J. (2011) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2011.01.005 · Cited by 7
HPV-16E6 can induce multiple site phosphorylation of p53
Huang, H. (1994) · Oncology Reports · doi:10.3892/or_00000232 · Cited by 7
Miyanaga, A., Matsumoto, M., Beck, J. A., Horikawa, I., Oike, T., Okayama, H., Tanaka, H., Burkett, S. S., Robles, A. I., Ma, K., et al. (2021) · BMC Cancer · doi:10.1186/s12885-021-07905-6 · Cited by 7
Overexpression of RFT induces G1–S arrest and apoptosis via p53/p21Waf1 pathway in glioma cell
Kano, H., Arakawa, Y., Takahashi, J. A., Nozaki, K., Kawabata, Y., Takatsuka, K., Kageyama, R., Ueba, T., & Hashimoto, N. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.03.120 · Cited by 7
Cellular response to DNA damage. Link between p53 and DNA-PK
Salles-Passador, I., Fotedar, A., & Fotedara, R. (1999) · Comptes Rendus de l Académie des Sciences - Series III - Sciences de la Vie · doi:10.1016/s0764-4469(99)80032-8 · Cited by 7
Nanua, S., & Yoshimura, F. K. (2004) · Journal of Virology · doi:10.1128/jvi.78.10.5088-5096.2004 · Cited by 7
Pond, C. D., Leachman, S. A., & Warters, R. L. (2004) · Radiation Research · doi:10.1667/rr3156 · Cited by 7
Generation and Application of Phospho-specific Antibodies for p53 and pRB
Taya, Y., Nakajima, K., Yoshizawa‐Kumagaye, K., & Tamai, K. (2003) · Humana Press eBooks · doi:10.1385/1-59259-329-1:17 · Cited by 7
Self-citationTumor Deprivation of Oxygen and Tumor Suppressor Gene Function
Yun, Z., & Giaccia, A. J. (2003) · Humana Press eBooks · doi:10.1385/1-59259-329-1:485 · Cited by 7
Ataxia-telangiectasia, ATM and genomic stability: maintaining a delicate balance
Shiloh, Y. (1998) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(98)00020-1 · Cited by 7
Szkanderová, S., Vávrová, J., Řezáčová, M., Vokurková, D., Pavlová, Š., Šmardová, J., & Stulík, J. (2003) · Folia Biologica · doi:10.14712/fb2003049050191 · Cited by 29
Efficient Activation of Apoptotic Signaling during Mitotic Arrest with AK301
Chopra, A. S., Bond, M. J., Bleiler, M., Yeagley, M. G., Wright, D. L., & Giardina, C. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153818 · Cited by 6
Pesi, R., Allegrini, S., Garcia‐Gil, M., Piazza, L., Moschini, R., Jordheim, L. P., Camici, M., & Tozzi, M. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137004 · Cited by 6
UVC-induced apoptosis in Dubca cells is independent of JNK activation and p53Ser-15 phosphorylation
Chathoth, S., Thayyullathil, F., Hago, A., Shahin, A., Patel, M. C., & Galadari, S. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.04.040 · Cited by 6
Jilani, K. E. B., Gaillard, J., Petit, F., Arnoult, D., Roumier, A.-S., Labalette, M., Ameisen, J., & Estaquier, J. (2002) · Biology of the Cell · doi:10.1016/s0248-4900(02)01184-x · Cited by 6
A Chromatin-Focused siRNA Screen for Regulators of p53-Dependent Transcription
Sammons, M. A., Zhu, J., & Berger, S. L. (2016) · G3 Genes Genomes Genetics · doi:10.1534/g3.116.031534 · Cited by 5
Skalka, G., Hall, H., Somers, J., Bushell, M., Willis, A. E., & Malewicz, M. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1601476 · Cited by 6
Huynh, H. T., Nguyen, T., Panasci, L., & Do, P. (2004) · Cancer · doi:10.1002/cncr.20670 · Cited by 5
Lee, S. C., & Chan, J. (2012) · PubMed · Cited by 5
Lakatos, E., Salehi‐Reyhani, A., Barclay, M., Stumpf, M. P. H., & Klug, D. R. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177336 · Cited by 5
Theoretical analysis of the delay on the p53 micronetwork
Wang, D., Liu, N., Yang, H., & Yang, L. (2020) · Advances in Difference Equations · doi:10.1186/s13662-020-02799-3 · Cited by 5
The DNA Damage Response Mediates Apoptosis and Tumor Suppression
Baran, K., Rodríguez, D. A., & Green, D. R. (2013) · Springer eBooks · doi:10.1007/978-1-4614-9302-0_7 · Cited by 6
Tawara, H. (2007) · Frontiers in bioscience · doi:10.2741/2674 · Cited by 5
p53 Protein and Nonmelanoma Skin Cancer
Melnikova, V. O., & Ananthaswamy, H. N. (2007) · Springer eBooks · doi:10.1007/0-387-35098-5_8 · Cited by 5
Wald-Altman, S., Pichinuk, E., Kakhlon, O., & Weil, M. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.027938 · Cited by 5
Ashcroft, M. A., & Vousden, K. H. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-230-2_7 · Cited by 5
Han, J., Tang, F.-M., Pu, D., Xu, D., Wang, T., & Li, W. (2014) · Tumori Journal · doi:10.1177/1430.15824 · Cited by 5
Human DNA polymerase ε : expression, phosphorylation and protein-protein interactions
Tuusa, J. T. (2001) · Cited by 5
The dual fate of DYRK2 in cancer: balancing the light and dark side of tumorigenesis
Suanes-Cobos, L., Torres-Ramos, M., Aguilera-Ventura, I., Serrano-Yubero, A., & Calzado, M. A. (2026) · Cancer and Metastasis Reviews · doi:10.1007/s10555-025-10311-0 · Cited by 4
Splicing DNA Damage Adaptations for the Management of Cancer Cells
Singh, A. K., Yadav, D., & Malviya, R. (2023) · Current Gene Therapy · doi:10.2174/0115665232258528231018113410 · Cited by 4
Activation of p53 by Sodium Selenite Switched Human Leukemia NB4 Cells From Autophagy to Apoptosis
Li, Z., Shi, K., Guan, L., Jiang, Q., Yang, Y., & Xu, C. (2014) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504014x14024160459087 · Cited by 4
Tumour Biology: p53 Gene Mechanisms
Zulfin Shaikh Niranjan, K. C. (2015) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000344 · Cited by 4
The dichotomous effects of caffeine on homologous recombination in mammalian cells
Magwood, A. C., Mundia, M. M., Pladwig, S., Mosser, D. D., & Baker, M. D. (2020) · DNA repair · doi:10.1016/j.dnarep.2020.102805 · Cited by 4
Wilson, P. F., & Bedford, J. S. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5897-7.00001-9 · Cited by 5
The role of p53 in the DNA damage-related ubiquitylation of S2P RNAPII
Borsos, B. N., Pantazi, V., Páhi, Z. G., Majoros, H., Újfaludi, Z., Berzsenyi, I., & Pankotai, T. (2022) · PLoS ONE · doi:10.1371/journal.pone.0267615 · Cited by 4
Ma, R., Zhang, M., Xi, J., Li, J., Ma, Y., Han, B., Che, T., Ma, Z., Tian, J., & Bai, Z. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.978464 · Cited by 4
Targeted Molecular Therapy in Palliative Cancer Management
Staats, H., Cassidy, C. S., Kelso, J. D., Mack, S. C., Morand, S. M., Choucair, K., Qaqish, H., Willis, O., Craig, D. J., Duff, J. M., et al. (2020) · Insights in Biomedicine · doi:10.36648/2572-5610.4.4.68 · Cited by 4
DNA Structure and Polymerase Fidelity: A New Role for A-DNA
Timsit, Y. (2000) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2000.10506617 · Cited by 4
Loss of Brcc3 in Zebrafish Embryos Increases Their Susceptibility to DNA Damage Stress
Wang, Z., Wang, C., Zhai, Y., Bai, Y., Wang, H., & Rong, X. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212108 · Cited by 3
Assessing phototoxic drug properties of hydrochlorothiazide using human skin biopsies
Hohl, M., Götzinger, F., Jäger, S., Wagmann, L., Tokcan, M., Tschernig, T., Reichrath, J., Federspiel, J. M., Boor, P., Meyer, M. R., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-08064-1 · Cited by 4
p53 in Human Cancer — Somatic and Inherited Mutations and Mutation-independent Mechanisms
Moll, U. M., & Concin, N. (2007) · Springer eBooks · doi:10.1007/0-387-30127-5_6 · Cited by 3
Ichwan, S. J. A., & Ikeda, M. (2008) · Journal of Oral Biosciences · doi:10.1016/s1349-0079(08)80023-0 · Cited by 3
Dimitrova, N., Staneva, D., Popov, B. N., Alexandrova, A., Georgieva, M., & Miloshev, G. A. (2023) · Journal of Experimental Biology and Agricultural Sciences · doi:10.18006/2023.11(2).405.415 · Cited by 3
Chapter 3 Interactions between the cell cycle and the myogenic program
Huang, J., & Thayer, M. J. (2002) · Advances in developmental biology and biochemistry · doi:10.1016/s1569-1799(02)11003-3 · Cited by 3
The Role of p53 Molecule in Radiation and Hyperthermic Therapies
Yasumoto, J.-I., Takahashi, A., Ohnishi, K., & Ohnishi, T. (2003) · Eisei kagaku · doi:10.1248/jhs.49.273 · Cited by 3
Tibbetts, R. S., & Abraham, R. T. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-218-0_15 · Cited by 3
Stress-mediated Sin3B activation leads to negative regulation of subset of p53 target genes
Kadamb, R., Mittal, S., Bansal, N., & Saluja, D. (2015) · Bioscience Reports · doi:10.1042/bsr20150122 · Cited by 3
RetractedErratum to: Controlling the response to DNA damage by the APC/C-Cdh1
de Boer, H. R., Llobet, S. G., & van Vugt, M. A. T. M. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2279-x · Cited by 3
Burrell, P. E., Fleenor, D. E., Nicholson, O. M., Shao, C., & Kastan, M. B. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2518589122 · Cited by 2
Self-citationKwon, Y., Yoon, H., Han, J., Park, J. W., & Jang, K. L. (2026) · FEBS Letters · doi:10.1002/1873-3468.70275 · Cited by 2
Regulation of p53 Activity and Associated Checkpoint Controls
Post, S. M., Quintás‐Cardama, A., & Lozano, G. (2009) · Humana Press eBooks · doi:10.1007/978-1-60761-178-3_11 · Cited by 2
Changes in Whole Blood Gene Expression after Computed Tomography in Children: A Pilot Study
(2015) · Gene Expression to Genetical Genomics · doi:10.4137/gegg.s21551 · Cited by 2
Legartová, S., Fagherazzi, P., Goswami, P., Brázda, V., Lochmanová, G., Koutná, I., & Bártová, E. (2022) · Biochimie · doi:10.1016/j.biochi.2022.09.013 · Cited by 2
Marchetti, F., & Wyrobek, A. J. (2009) · University of North Texas Digital Library (University of North Texas) · Cited by 2
p53 protein and the response of human skin to UV
Decraene, D., Agostinis, P., Pupe, A., Haes, P. D., & Garmyn, M. (2001) · Comprehensive series in photosciences · doi:10.1016/s1568-461x(01)80056-9 · Cited by 2
Functional Analysis of Chromodomain Helicase DNA Binding Protein 2(CHD2) mediated Genomic Stability
Rajagopalan, S. (2010) · Cited by 2
Constitutive Photomorphogensis Protein1 (COP1) mediated p53 pathway and its oncogenic role
Rabbani, M. G., Hossain, S. A., Islam, K. K., & Uddin, S. N. (2014) · Biomedical Research and Therapy · doi:10.7603/s40730-014-0022-5 · Cited by 1
Pandita, T. K. (2001) · Advances in cell aging and gerontology · doi:10.1016/s1566-3124(01)08004-x · Cited by 2
Transient Dephosphorylation of p53 Serine 376 as an Early Response to Ionizing Radiation
Warters, R. L., Gaffney, D. K., Kramer, G. F., Martinez, J. D., & Cress, A. E. (2009) · Radiation Research · doi:10.1667/rr1576.1 · Cited by 2
p53, Apoptosis, and Chemosensitivity
Lowe, S. W. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-720-8_2 · Cited by 2
Role for PKCδ on Apoptosis in the DNA Damage Response
Yoshida, K. (2011) · InTech eBooks · doi:10.5772/24383 · Cited by 1
Metadata
- Authors
- Siliciano, J. D., Canman, C. E., Taya, Y., Sakaguchi, K., Appella, E., & Kastan, M. B.
- Affiliations
- National Institutes of Health (US)
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 1997-12-15
- Volume
- 11
- Issue
- 24
- Pages
- 3471-3481
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- PMC
- PMC316806
- OpenAlex
- W2149013144
- Cited by
- 818
- References
- 71
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 5 · 2023: 7 · 2022: 10 · 2021: 10 · 2020: 12 · 2019: 14 · 2018: 12 · 2017: 18 · 2016: 22 · 2015: 17 · 2014: 24 · 2013: 21 · 2012: 27
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- American Society of Hematology
- National Institutes of Health (ES05777)
- National Cancer Institute (CA71387, R01CA071387)
- National Institute of Environmental Health Sciences (R01ES005777, R37ES005777, ES05777)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- p53, DNA damage response, ionizing radiation, UV irradiation, post-translational modification, ATM kinase, lymphoblasts
- MeSH terms
- Ataxia Telangiectasia, Binding Sites, Cells, Cultured, DNA, DNA Damage, Electrophoresis, Humans, Lymphocytes, Nuclear Proteins, Peptide Fragments, Phosphorylation, Protein Processing, Post-Translational, Proto-Oncogene Proteins, Serine, Ultraviolet Rays, Signal Transduction, Tumor Suppressor Protein p53, Cyclins, Cyclin-Dependent Kinase Inhibitor p21, Proto-Oncogene Proteins c-mdm2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review